30 Mar 2016 16:06
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Appointment of Adviser
Cambridge Cognition Holdings plc, (AIM: COG), the specialist developer of computerised tests for detection and monitoring of neuropsychological disorders, is pleased to announce the appointment of Hybridan LLP as the Company's Joint Broker, with immediate effect. FinnCap remains Nominated Adviser to the Company.
Enquiries:
Cambridge Cognition Holdings plc | www.cambridgecognition.com |
Steven Powell, Chief Executive Officer | Tel: 01223 810 700 |
Nick Walters, Chief Financial Officer |
|
|
|
finnCap Ltd (Nomad and Joint Broker) |
Tel: 020 7220 0500 |
Geoff Nash/Simon Hicks Malar Velaigam
| (Corporate Finance) (Corporate Broking) |
Hybridan LLP (Joint Broker) Claire Louise Noyce (Corporate Broking) | Tel: 020 3764 2341 |
About Cambridge Cognition
Cambridge Cognition is a world leading provider of computerised cognitive assessment products. The company's range of touch-screen CANTAB™ neuropsychological tests, highly validated over one thousand peer-reviewed publications, are used by both academic scientists in their research, and clinical researchers in the pharmaceutical industry, to maximise knowledge of cognitive function. In addition, the company is committed to broadening the access to this technology and is developing clinical healthcare products to improve the monitoring, management and maintenance of cognitive health and wellbeing. Using these assessments, clinicians can identify and stratify patients so that patient referrals are accurate and efficient, enabling health and social care providers to deliver more effective advice, treatments and care - leading to better outcomes for patients and their families.
Cambridge Cog (COG)